| Bioactivity | Fesomersen (sodium) is an antisense oligonucleotide designed to inhibit the production of Factor XI. |
| Name | Fesomersen sodium |
| CAS | 2380288-85-5 |
| Formula | C296H434N82O156P20S13Na20 |
| Molar Mass | 9113.01 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gómez-Outes A, Suárez-Gea ML, Pérez-Cabeza AI, García-Pinilla JM. Pharmacotherapy for stroke prevention in nonvalvular atrial fibrillation: current strategies and future directions. Expert Opin Pharmacother. 2022;23(17):1941-1955. [2]. Fredenburgh JC, Weitz JI. News at XI: Moving Beyond Factor Xa Inhibitors [published online ahead of print, 2023 Apr 26]. J Thromb Haemost. 2023;S1538-7836(23)00343-4. doi:10.1016/j.jtha.2023.04.021 |
Fesomersen sodium
CAS: 2380288-85-5 F: C296H434N82O156P20S13Na20 W: 9113.01
Fesomersen (sodium) is an antisense oligonucleotide designed to inhibit the production of Factor XI.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.